Chester County News and Community Website
PHILADELPHIA, PA — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, announced yesterday the closing of its initial public offering …
Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, this week announced the pricing of its underwritten public …
Read More WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, this week announced that it intends to offer and …
Read More
EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) on Friday announced the closing of its previously announced underwritten public offering of 15,333,332 shares of its common stock, including 1,999,999 shares …
Read More
MALVERN, PA — PQ Group Holdings Inc. (NYSE: PQG) yesterday announced the pricing of the previously announced underwritten public offering by certain of its stockholders of 12,500,000 shares of its …
Read More
MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) yesterday announced that it closed the previously announced registered direct offering with healthcare-focused institutional investors for the sale of an aggregate of 10 …
Read More MALVERN, PA — PQ Group Holdings Inc. (NYSE: PQG) this week announced that certain of its stockholders intend to offer for sale 12,500,000 shares of its common stock pursuant to …
Read More
MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that it has entered into a definitive agreement with institutional and …
Read More MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, announced …
Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from …
Read More